Sinclair Pharma H1 losses widen as revenue rises
27th Sep 2018 14:12
(Sharecast News) - Dermatology product maker Sinclair Pharma said first half pre-tax losses widened to £11.4m from £7.8m.
Read moreSinclair Pharma agrees to potential 32p a share offer from Huadong
29th Aug 2018 08:16
(Sharecast News) - Sinclair Pharma has agreed to a potential takeover offer by a subsidiary of China's Huadong Medicine Co for 32p a share in cash.
Read moreDirector dealings: Sinclair Pharma veteran joins buying splurge
5th Oct 2016 15:14
(ShareCast News) - Sinclair Pharma director Jeff Thompson bought his first shares in the company after they failed to perk up in response to the aesthetic dermatology specialist's staff restructuring last month. The US dermatology industry veteran and partner of Florida-based healthcare private equi
Read moreSinclair Pharma posts jump in half-year revenues
19th Jul 2016 16:17
(ShareCast News) - Sinclair Pharma, whose healthcare products unit was purchased by Alliance Pharma last year, reported a jump in revenue for the six months ended 30 June. Revenues rose to £17.2m from £7.7m in the first interim period, which was hit by planned destocking. Silhouette, the company's
Read moreDirector dealings: Telit Communications chairman adds to stake
31st May 2016 14:55
(ShareCast News) - Telit Communication chairman Enrico Testa has shown his confidence that the company's hardware and software products are gaining traction with industry. Testa spent £226,500 to add 100,000 shares at a price of 226.5p to take his total ownership of the internet of things (IoT) comp
Read moreSinclair IS Pharma shares drop despite strong end to the year
5th Aug 2015 15:59
(ShareCast News) - Shares in Sinclair IS Pharma moved lower after the company reported a strong second half. Sinclair IS Pharma shares were down by 2.19% to 44.75p at 16:18 BST. The cosmetic treatment provider, which is in talks to be fully or partially sold, said like-for-like growth for the year
Read moreSinclair IS Pharma hails aesthetic growth as strategic talks continue
17th Feb 2015 13:35
Interim results at Sinclair IS Pharma matched analyst forecasts, but the medicinal and aesthetic dermatology specialist warned the weaker euro and difficulties with Russia may weigh on the second half. The AIM-listed company said a potential sale of the business remains on the cards, as a result of
Read moreTuesday broker round-up UPDATE
7th Oct 2014 09:45
African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 1500p and an underperform rating. Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation. Antofagasta: Canacc
Read moreSector movers: Shire and AZN lead pharma stocks lower on M&A risk
6th Aug 2014 14:13
The pharmaceutical sector dropped on Wednesday on the back of fears about risks to mergers and acquisitions (M&A) activity, with Shire sinking sharply. Concerns that stricter rules on so-called 'tax inversion' in the US could scupper Abbvie's £32bn takeover of London-listed Shire dented the latter'
Read moreTuesday broker round-up UPDATE
29th Jul 2014 09:37
Abderdeen Asset Management: Berenberg cuts target price from 530p to 510p and maintains a buy recommendation. African Barrick Gold: Numis takes target price from 260p to 330p upgrading from hold to buy. Anglo American: Deutsche Bank increases target price from 1590p to 1650p and reiterates a hold
Read moreRM2 International boss buys £0.6m of shares
18th Jul 2014 14:51
Pallet manufacturer RM2 International, which floated on the stock market at the start of the year, has announced that its boss John Walsh has bought one million shares in the company. Former banker Walsh, who has been RM2's Chief Executive since its inception, purchased the shares at a price of 61.
Read moreTuesday broker round-up UPDATE
15th Jul 2014 08:53
Admiral Group: Numis moves target price from 1710p to 1720p, while downgrading from buy to add. African Barrick Gold: UBS initiates with a target price of 260p and a buy recommendation. Ashtead Group: Berenberg initiates with a target price of 1110p and a buy recommendation. British American Taba
Read moreXaar's R&D Director builds stake following lower profit guidance
25th Jun 2014 15:50
Ramon Borrell, the Research & Development (R&D) Director of FTSE 250 member Xaar, continued to build his stake in the inkjet printheads supplier with the purchase of 40,000 shares. The deal comes just days after the company lowered its guidance for full-year revenues and profit margin, saying the
Read moreHydroDec directors add 4.36m shares, stock value jumps
10th Jun 2014 15:52
A total of 4.36m shares were purchased by seven of HydroDec's board members this week, the oil technology group revealed on Tuesday. The transactions come just a few weeks after the group reported wider losses in the 12 months ended December 31st at $17.45m, compared to $14.20m a year earlier. T
Read moreOcado CFO builds stake after fifth of shareholders oppose remuneration report
8th May 2014 15:45
Duncan Tatton-Brown, the Chief Financial Officer of Ocado Group, has acquired 145,988 pounds-worth of shares in the grocery delivery group. The CFO, who joined the board in September 2012, bought a total of 47,865 shares at 305p each, increasing his stake in the company to 107,865 shares. That c
Read more